MedPath
NMPA Approval

Brimonidine Tartrate Eye Drops

H20150504

April 23, 2020

H20150504

Drug Information

酒石酸溴莫尼定滴眼液

沐利汀

沐利汀

滴眼剂

5ml:10mg

化学药品

April 23, 2020

April 22, 2025

Company Information

Applicant Company

SANDOZ, INC.

100 College Rd W, Princeton, NJ 08540 United States of America.

Manufacturing Company

6201 South Freeway Fort Worth, Texas 76134

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath